---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-023321"
form_type: "8-K"
ticker: "SBC"
cik: "0001930313"
company_name: "SBC Medical Group Holdings Inc"
filed_at: "2025-08-13T23:59:59+00:00"
generated_at: "2026-05-17T14:02:21.053513+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# SBC Medical Q2 2025 revenue $43M (-18% YoY), net income $2.5M (-87% YoY)

## Summary
- Total revenues $43M, down 18% YoY; income from operations $15M, down 47% YoY.
- Net income attributable to SBC Medical $2.5M, down 87% YoY; EPS $0.02 vs $0.20.
- EBITDA $15M (46% decrease); EBITDA margin 35% vs 53% prior year.
- Franchise locations 259 (+36 YoY); customers 6.31M (+14% YoY); repeat rate 72%.

## SEC filing metadata
- accession: 0001641172-25-023321
- form_type: 8-K
- ticker: SBC
- cik: 0001930313
- company_name: SBC Medical Group Holdings Inc
- filed_at: 2025-08-13T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1930313/000164117225023321/0001641172-25-023321-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1930313/000164117225023321/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-023321
- JSON: https://secwatch.observer/filing/0001641172-25-023321.json
- Plain text: https://secwatch.observer/filing/0001641172-25-023321.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.